2024-03-01 2025-02-28 false Capium Accounts Production 1.1 13919239 2024-03-01 2025-02-28 13919239 bus:AbridgedAccounts 2024-03-01 2025-02-28 13919239 bus:FRS102 2024-03-01 2025-02-28 13919239 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 13919239 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 13919239 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 13919239 2024-03-01 2025-02-28 13919239 2025-02-28 13919239 bus:RegisteredOffice 2024-03-01 2025-02-28 13919239 core:WithinOneYear 2025-02-28 13919239 core:AfterOneYear 2025-02-28 13919239 1 2024-03-01 2025-02-28 13919239 bus:Director1 2024-03-01 2025-02-28 13919239 bus:Director1 2025-02-28 13919239 bus:Director1 2023-03-01 2024-02-29 13919239 2023-03-01 13919239 bus:LeadAgentIfApplicable 2024-03-01 2025-02-28 13919239 2023-03-01 2024-02-29 13919239 2024-02-29 13919239 core:WithinOneYear 2024-02-29 13919239 core:AfterOneYear 2024-02-29 13919239 bus:EntityAccountantsOrAuditors 2023-03-01 2024-02-29 13919239 bus:OrdinaryShareClass1 2024-03-01 2025-02-28 13919239 bus:OrdinaryShareClass1 2025-02-28 13919239 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 13919239 bus:OrdinaryShareClass1 2024-02-29 13919239 core:CostValuation core:Non-currentFinancialInstruments 2025-02-28 13919239 core:CostValuation core:Non-currentFinancialInstruments 2024-02-29 13919239 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-02-28 13919239 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 13919239 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 13919239 core:Non-currentFinancialInstruments 2025-02-28 13919239 core:Non-currentFinancialInstruments 2024-02-29 13919239 core:ShareCapital 2025-02-28 13919239 core:ShareCapital 2024-02-29 13919239 core:RetainedEarningsAccumulatedLosses 2025-02-28 13919239 core:RetainedEarningsAccumulatedLosses 2024-02-29 13919239 dpl:Item1 2024-03-01 13919239 dpl:Item1 2025-02-28 13919239 dpl:Item1 2023-03-01 13919239 dpl:Item1 2024-02-29 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 13919239
England and Wales
DESTEK PATENT LTD
Abridged Accounts
Period of accounts Start date: 01 March 2024 End date: 28 February 2025

Registered Number: 13919239 DESTEK PATENT LTD Statement of Financial Position As at 28 February 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Current assets |  |  |
Debtors |  | 112,506 |  | 88,109
Cash at bank and in hand |  | 4,037 |  | 311
|  | 116,543 |  | 88,420
Creditors: amount falling due within one year |  | (22,964) |  | (23,700)
Net current assets |  | 93,579 |  | 64,720
Total assets less current liabilities |  | 93,579 |  | 64,720
Creditors: amount falling due after more than one year |  | (256,118) |  | (226,218)
Provisions for liabilities |  | 124 |  | (74)
Net assets |  | (162,415) |  | (161,572)
Capital and reserves |  |  |
Called up share capital | 4 | 100 |  | 100
Profit and loss account |  | (162,515) |  | (161,672)
Shareholders' funds |  | (162,415) |  | (161,572)
For the year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 03 December 2025 and were signed by:
------------------------------- Ahmet Faruk YAMAN KARADENIZ Director
1

DESTEK PATENT LTD Notes to the Abridged Financial Statements For the year ended 28 February 2025
General Information DESTEK PATENT LTD is a private company, limited by shares, registered in England and Wales, registration number 13919239, registration address Unit 6 Hill View Studios, 160 Eltham Hill , London, United Kingdom, SE9 5EA. The trading address of the company is Aviation House, 125 Kingsway, London, England , WC2B 6NH. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Website cost Planning and operating costs for the company's website are charged to the income statement as incurred. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Deferred taxation Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Current and deferred tax assets and liabilities are not discounted.
2. | Staff Costs
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Wages and salaries | 48,769 |  | 68,884
Social security costs | 3,896 |  | 7,229
Pension costs, defined contribution plan | - |  | 376
| 52,665 |  | 76,489
Average number of employees during the year | Number |  | Number
Administration | 1 |  | 1
Marketing | 1 |  | 1
| 2 |  | 2
3. | Average number of employees Average number of employees during the year was 2 (2024 : 2).
4. | Share Capital Authorised 100 Class A shares of £1.00 each
Allotted, called up and partly paid | 2025 £ |  | 2024 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
2